IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund decreased its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 18.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,882 shares of the medical research company’s stock after selling 2,259 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in IQVIA were worth $2,286,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. AdvisorNet Financial Inc raised its position in shares of IQVIA by 327.6% in the fourth quarter. AdvisorNet Financial Inc now owns 124 shares of the medical research company’s stock worth $29,000 after acquiring an additional 95 shares during the period. BKM Wealth Management LLC purchased a new position in IQVIA during the fourth quarter worth approximately $32,000. Activest Wealth Management acquired a new stake in IQVIA in the fourth quarter valued at approximately $35,000. CVA Family Office LLC acquired a new stake in IQVIA in the fourth quarter valued at approximately $43,000. Finally, CoreFirst Bank & Trust purchased a new stake in shares of IQVIA in the third quarter valued at approximately $44,000. 89.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at IQVIA

In related news, insider Ari Bousbib sold 31,678 shares of the firm’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $250.53, for a total transaction of $7,936,289.34. Following the completion of the sale, the insider now directly owns 796,752 shares of the company’s stock, valued at approximately $199,610,278.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Ari Bousbib sold 31,678 shares of the company’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $250.53, for a total value of $7,936,289.34. Following the transaction, the insider now directly owns 796,752 shares in the company, valued at approximately $199,610,278.56. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Kevin C. Knightly sold 8,607 shares of IQVIA stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of $250.17, for a total transaction of $2,153,213.19. Following the completion of the sale, the insider now owns 5,251 shares of the company’s stock, valued at approximately $1,313,642.67. The disclosure for this sale can be found here. Insiders have sold 41,285 shares of company stock worth $10,331,003 over the last quarter. 1.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on IQV shares. Truist Financial lifted their price target on shares of IQVIA from $286.00 to $297.00 and gave the company a “buy” rating in a research note on Tuesday, February 27th. UBS Group lifted their target price on shares of IQVIA from $240.00 to $300.00 and gave the company a “buy” rating in a research report on Thursday, February 15th. SVB Leerink initiated coverage on shares of IQVIA in a research report on Monday, February 26th. They set an “outperform” rating and a $290.00 price target for the company. BTIG Research started coverage on IQVIA in a report on Tuesday, February 13th. They issued a “buy” rating and a $285.00 price objective on the stock. Finally, Barclays increased their target price on IQVIA from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Thursday, February 15th. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, IQVIA presently has an average rating of “Moderate Buy” and an average target price of $256.80.

IQVIA Trading Down 2.8 %

Shares of IQV stock opened at $234.08 on Friday. IQVIA Holdings Inc. has a twelve month low of $167.42 and a twelve month high of $261.73. The stock has a market cap of $42.49 billion, a price-to-earnings ratio of 32.11, a PEG ratio of 2.33 and a beta of 1.50. The company’s 50-day moving average price is $245.35 and its 200-day moving average price is $222.77. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 2.12.

IQVIA (NYSE:IQV) last posted its quarterly earnings results on Wednesday, February 14th. The medical research company reported $2.84 earnings per share for the quarter, beating the consensus estimate of $2.82 by $0.02. IQVIA had a net margin of 9.06% and a return on equity of 29.32%. The business had revenue of $3.87 billion during the quarter, compared to analysts’ expectations of $3.80 billion. During the same quarter in the prior year, the company posted $2.54 EPS. The business’s revenue for the quarter was up 3.5% on a year-over-year basis. As a group, equities analysts predict that IQVIA Holdings Inc. will post 10.11 earnings per share for the current year.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.